Recommendations Essential in Human Papillomavirus Vaccination Decision

Published Online: Wednesday, February 19, 2014
Follow Pharmacy_Times:
Recommendations from health care professionals may improve uptake of the human papillomavirus (HPV) vaccine, according to a systematic review published in the January 2014 issue of JAMA Pediatrics.

Vaccination against HPV has remained low among adolescents in the United States, and the researchers of the study set out to determine the major barriers limiting vaccination. Using PubMed, 55 relevant articles conducted from 2009 and on were identified and included in the review. Data from the included studies were categorized according to the target population addressed in the article: health care professionals, parents, underserved and disadvantaged populations, and boys.

Health care professionals frequently reported financial concerns and the attitudes of parents as barriers to giving the shot to their patients. Some parents also cited the cost of the vaccine as a barrier, while many reported irregular preventive care, concerns about the vaccine’s effect on their child’s sexual behavior, and a perceived low risk for infection. Despite these barriers, parents consistently reported health care professional recommendations to be one of the most important factors when making the decision to vaccinate their children.

To increase HPV vaccination among adolescents, the authors suggest that the barriers of specific populations be considered.

Related Articles
The FDA today approved the human papillomavirus 9-valent vaccine recombinant for the prevention of 5 more types of HPV than the previously approved Gardasil.
In light of new data that shows the 2014-2015 flu season could be severe, the US Centers for Disease Control and Prevention is urging immediate influenza vaccination for all unvaccinated individuals, as well as prompt antiviral drug treatment for those who develop flu and have a high risk of complications.
In support of National Influenza Vaccination Week, Rite Aid is reducing the price of flu shots by $5 to encourage people who have not yet received their annual flu shot to get vaccinated. From now through December 13, flu shots will be available from Rite Aid certified immunizing pharmacists at Rite Aid pharmacies nationwide at a reduced price of only $26.99*, subject to state regulations. Flu shots are covered by most insurance plans, including Medicare Part B.
A powdered measles vaccine delivered by a puff of air triggered no adverse side effects during early human testing, and future clinical trials will likely establish its efficacy.
Latest Issues
$auto_registration$